London - Institute of Cancer Research

The Institute of Cancer Research (ICR) aims to develop novel treatments across the range of adult cancers and identify which patients are most likely to benefit from particular therapies. Areas of expertise include molecular pharmacodynamics, diagnostics (including DNA sequencing) and imaging (MRI and PET). Like other Centres the ICR works with other ECMCs to conduct early phase clinical trials.

Focus

Molecular pathology, imaging, pharmacokinetics (PK) and pharmacodynamics (PD)

Disease Area

Relevant to all types of cancer, breast, colon, rectal, kidney, lung, melanoma, ovarian, pancreatic, protate, sarcoma

Goals

For further information on the goals and objectives of ICR ECMC go to:

More about Goals

Skills

ICR ECMC principal investigators and staff have a diverse range of skills and expertise.

More about Skills

Facilities

ICR ECMC has access to a range of research facilities that are utilised in studies.

More about Facilities

Achievements

To learn more about the scientific and operational achievements of ICR ECMC go to:

More Achievements

Prof S. Kaye
Head of Drug Development Unit (DDU)

Dr J. de Bono
Senior Lecturer and Consultant in Medical Oncology

Dr U. Banerji
Senior Lecturer and Consultant in Medical Oncology

Dr Rhoda Molife
Senior Clinical Fellow in Drug Development

Salil Malvankar
Head of Data Management Team

Ms Alex Pritchard
Clinical Trials Manager and DDU Administrator

Ms Alex Pritchard
Tel: +44 (0) 20 8722 4302

Address:

ICR Experimental Cancer Medicine Centre
Sycamore House
Section of Medicine, Room DM21
Royal Marsden Hospital
Downs Road
Sutton
Surrey
SM2 5PT

You can also find out about trials recruiting in London on the CancerHelp UK clinical trials database.